ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner

Liu Q, Huang CS, Chen S, Zhu YQ, Huang XT, Zhao GY, Xu QC, Shi YH, Li W, Wang R, Yin XY. ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A-to-I editing manner. Cell Prolif. 2024 May 21:e13659.

Used in this study:immunodeficient B-NDG mice